English

Pfizer

Health news

Lyme disease vaccine shows strong results in clinical trial

ADVERTISEMENT

ADVERTISEMENT

Business

Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera

Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

Markets

Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat

Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.

Brussels, My Love?

"Brussels, my love?" EU heads to London for major Reset Summit

An EU–UK summit took place in London this week marking a significant step in post-Brexit relations.

Europe News

Commission's Pfizergate loss hailed as ‘victory for transparency’

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and Pfizer’s CEO. Critics say the Commission’s actions undermine public trust and accountability, calling for greater transparency in decision-making.

ADVERTISEMENT

Europe News

Nothing to see here! These politicians also deleted text messages

From Nokia-gate to Covid times, several EU politicians failed to give the public access to crucial Whatsapp conversations.

Europe News

EU Commission loses on all counts in Pfizergate legal case

The EU’s top court annulled the Commission’s decision to deny the newspaper New York Times access to messages exchanged between President Ursula von der Leyen and Pfizer CEO Albert Bourla, finding that the EU executive failed to plausibly explain why it does not possess the texts.

Europe News

Ukraine’s diplomatic checkmate, and where it leaves Putin

All eyes will be on Turkey this Thursday, where peace talks between Russia's and Ukraine's presidents are slated to occur. Will Putin show face? And if he doesn't, where does this leave him?

Health news

Pfizer stops work on potential obesity pill over patient liver injury

Pfizer had intended to move the drug into late-stage testing, but called it quits after a patient in a clinical trial experienced a potentially drug-related liver injury.

Health news

Pfizergate Commission transparency battle kicks off in European Court

The case opposing the New York Times and the EU Commission over its failure to disclose text messages between president Ursula von der Leyen and Pfizer CEO Albert Bourla about COVID-19 vaccine contracts has entered the hearing phase.

Europe News

The political power struggle over approving the Commission

The EU institutions have been on hold since the European elections in June. The EU executive was supposed to be up and running on December 1st, but a clash among political groups might delay the start.

Europe News

Von der Leyen Commission loses COVID vaccine transparency case

Von der Leyen's Commission has lost a controversial vaccines contracts transparency case on the eve of a crucial vote in the European Parliament to confirm her nomination as Commission President.

Health news

Pfizergate plaintiff asks leaders to sack von der Leyen and Commission

The plaintiff in the Pfizergate affair has called on the European Council to force the resignation of EU executive chief Ursula von der Leyen and the rest of her Commissioners in a letter seen by Euronews.

Health news

How the love story between von der Leyen and Pfizer turned sour

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story between Ursula von der Leyen and big pharma Pfizer.

Health news

Commission approves superbug-busting antibiotic

The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing.

Business

Have healthcare stocks been under the weather in 2023?

Euronews Business looks at how major healthcare stocks such as Pfizer and Moderna performed this year

No Comment

WATCH: Tornado slams North Carolina homes and businesses

A tornado heavily damaged a major Pfizer pharmaceutical plant in North Carolina on Wednesday, the latest in a string of extreme weather events plaguing the US.